Page 669 - WSAVA2018
P. 669

WSVA8-0135
DERMATOLOGY
VETERINARY SATISFACTION TRIAL WITH INJECTABLE CEFOVECIN SODIUM IN DOGS AS TREATMENT FOR SKIN INFECTIONS INCLUDING SUPERFICIAL PYODERMA, WOUNDS, AND ABSCESSES.
P. Pawar1, A. Wright2, A. Pavlock3
1Zoetis Inc, Zoetis India Limited, Parsippany, USA
2Zoetis Inc, International Outcomes Research, Parsippany, USA
3AMP Research Solutions, Veterinary Consultant - Outcome Reasearch, Pennsylvania, USA
INTRODUCTION
Cefovecin sodium is an injectable cephalosporin antibiotic, indicated for use as a treatment for susceptible skin infections including superficial pyoderma, wounds, and abscesses in dogs, provides clinical efficacy for
14 days, can be repeated up to one time, and is newly available for clinical practice in India.
OBJECTIVES
The objective of this study was to evaluate veterinary satisfaction based on clinical assessment of response to treatment with cefovecin sodium in client-owned dogs.
METHODS
107 dogs of various breeds, ranging in age from 2 months to 11 years, in 25 different veterinary practices
in India representing all regions of the country were administered 8 mg/kg cefovecin sodium subcutaneously for skin infections The date of examination/treatment, signalment and appearance of the dog, location of lesion(s), tentative diagnosis, and clinical reassessment/ outcome were recorded The veterinarian was also asked to provide visualization of the outcome through high image resolution digital photographs.
RESULTS
Outcomes were as follows: 90 cases classified as either excellent (5), good (6), or satisfying (79) and 8 classified as either indifferent (5) or unsatisfied (3); an outcome was not received for 9 cases. 10 dogs (9.35%) received a second injection.
Your Singapore, the Tropical Garden City
CONCLUSIONS
The overall satisfaction rate in this sample of dogs from India was 84.11% (90/107), calculated by pooling results from the outcomes of excellent, good, and satisfying. This study demonstrates the usefulness of cefovecin sodium as a treatment for skin infections including superficial pyoderma, wounds, and abscesses in dogs, as assessed by clinical response through the attending veterinarian.
           667
            













































































   667   668   669   670   671